VivoSeq
Other

Desmopressin

0

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Desmopressin is an early-stage landscape with 0 programs across 2 companies. The most active players are Ferring, Teva.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ferring logo

Ferring

0 programs

PreclinicalTeva logo

Teva

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed10 · 67%
Unknown status2 · 13%
Terminated2 · 13%
Enrolling by invitation1 · 7%

Clinical Trials

Trial Activity

15 trials

Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies
Enrolling by invitation·HHospital de Clinicas de Porto Alegre·Phase 4·NCT06622187·96 enrolled
Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population
Completed·UUniversity Ghent·Phase 4·NCT02584231·25 enrolled
The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
Completed·UUniversity of Aarhus·N/A·NCT02068560·64 enrolled
Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
Completed·Ferring logoFerring·Phase 3·NCT01262456·395 enrolled
Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
Completed·Ferring logoFerring·N/A·NCT02368730·23 enrolled
Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation
Completed·UUniversity Hospital, Ghent·Phase 4·NCT01036841·24 enrolled
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
Completed·Ferring logoFerring·Phase 3·NCT01223937·268 enrolled
Desmopressin Melt: Impact on Sleep and Daytime Functioning
Completed·UUniversity Hospital, Ghent·Phase 4·NCT01645475·30 enrolled
Desmopressin Acetate 0.2 mg Tablets, Fasting
Completed·Teva logoTeva·Phase 1·NCT00835211·48 enrolled
Desmopressin Response in the Young
Completed·Ferring logoFerring·Phase 3·NCT00230594·132 enrolled
Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction
Completed·TThe University of Hong Kong·N/A·NCT01382134·60 enrolled
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Terminated·MMount Sinai Hospital, Canada·Phase 2/3·NCT02262936·4 enrolled
Desmopressin for Bedwetting in Children With SCD
Terminated·MMontefiore Medical Center·Phase 4·NCT04420585·8 enrolled
Desmopressin for Bleeding Related to Low Body Temperature
Unknown status·TThe University of Hong Kong·Phase 4·NCT00902057·48 enrolled
Adding Desmopressin to Tamsulosin for Treatment of BPH
Unknown status·MMansoura University·Phase 4·NCT05945420·160 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)